The Latest Analyst Ratings For GeneDx Hldgs
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for GeneDx Holdings (NASDAQ:WGS) in the latest quarter, with a majority being bullish. The average 12-month price target has increased by 60% to $20.8. Key analysts have raised their price targets, reflecting positive sentiment towards the company's future performance.
June 26, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GeneDx Holdings (NASDAQ:WGS) has received mixed but predominantly bullish ratings from analysts. The average 12-month price target has increased by 60% to $20.8, with key analysts raising their targets, indicating positive sentiment towards the company's future performance.
The majority of analysts have given bullish ratings, and the significant increase in the average price target suggests positive sentiment towards GeneDx Holdings. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100